Disulfiram and BKM120 in Combination with Chemotherapy Impede Tumor Progression and Delay Tumor Recurrence in Tumor Initiating Cell-Rich TNBC
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Disulfiram and BKM120 in Combination with Chemotherapy Impede Tumor Progression and Delay Tumor Recurrence in Tumor Initiating Cell-Rich TNBC
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-01-14
DOI
10.1038/s41598-018-35619-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recent Advances in Antabuse (Disulfiram): The Importance of its Metal-binding Ability to its Anticancer Activity
- (2018) Maricela Viola-Rhenals et al. CURRENT MEDICINAL CHEMISTRY
- Quercetin suppresses breast cancer stem cells (CD44 + /CD24 − ) by inhibiting the PI3K/Akt/mTOR-signaling pathway
- (2018) Xiuli Li et al. LIFE SCIENCES
- Targeting cancer stem cells in the clinic: Current status and perspectives
- (2018) Stephanie Annett et al. PHARMACOLOGY & THERAPEUTICS
- Heterogeneity of Human Breast Stem and Progenitor Cells as Revealed by Transcriptional Profiling
- (2018) Justin A. Colacino et al. Stem Cell Reports
- Chemotherapy-Induced Ca 2+ Release Stimulates Breast Cancer Stem Cell Enrichment
- (2017) Haiquan Lu et al. Cell Reports
- miR-221/222 enhance the tumorigenicity of human breast cancer stem cells via modulation of PTEN/Akt pathway
- (2016) Bailong Li et al. BIOMEDICINE & PHARMACOTHERAPY
- Targeting ALDH1A1 by disulfiram/copper complex inhibits non-small cell lung cancer recurrence driven by ALDH-positive cancer stem cells
- (2016) Xinwei Liu et al. Oncotarget
- A Phase I Trial of BKM120 (Buparlisib) in Combination with Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive Metastatic Breast Cancer
- (2015) C. X. Ma et al. CLINICAL CANCER RESEARCH
- AKT Antagonist AZD5363 Influences Estrogen Receptor Function in Endocrine-Resistant Breast Cancer and Synergizes with Fulvestrant (ICI182780) In Vivo
- (2015) R. Ribas et al. MOLECULAR CANCER THERAPEUTICS
- PIK3CAH1047R induces multipotency and multi-lineage mammary tumours
- (2015) Shany Koren et al. NATURE
- Targeting Notch, Hedgehog and Wnt pathways in cancer stem cells: clinical update
- (2015) Naoko Takebe et al. Nature Reviews Clinical Oncology
- A Phase IIb Trial Assessing the Addition of Disulfiram to Chemotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer
- (2015) H. Nechushtan et al. ONCOLOGIST
- Concise Review: Targeting Cancer Stem Cells Using Immunologic Approaches
- (2015) Qin Pan et al. STEM CELLS
- Sox2 antagonizes the Hippo pathway to maintain stemness in cancer cells
- (2015) Upal Basu-Roy et al. Nature Communications
- ALDH/CD44 identifies uniquely tumorigenic cancer stem cells in salivary gland mucoepidermoid carcinomas
- (2015) April Adams et al. Oncotarget
- Mammosphere Formation Assay from Human Breast Cancer Tissues and Cell Lines
- (2015) Ylenia Lombardo et al. Jove-Journal of Visualized Experiments
- Targeting self-renewal pathways in cancer stem cells: clinical implications for cancer therapy
- (2015) A Borah et al. Oncogenesis
- High aldehyde dehydrogenase activity identifies cancer stem cells in human cervical cancer
- (2015) Shuyan Liu et al. Oncotarget
- Blocking the formation of radiation–induced breast cancer stem cells
- (2015) Yangyang Wang et al. Oncotarget
- PDGFR and Play Critical Roles in Mediating Foxq1-Driven Breast Cancer Stemness and Chemoresistance
- (2014) F. Meng et al. CANCER RESEARCH
- Targeting PI3K/mTOR Overcomes Resistance to HER2-Targeted Therapy Independent of Feedback Activation of AKT
- (2014) N. A. O'Brien et al. CLINICAL CANCER RESEARCH
- Phase I dose-escalation and -expansion study of buparlisib (BKM120), an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors
- (2014) Jordi Rodon et al. INVESTIGATIONAL NEW DRUGS
- Evaluation of Cancer Stem Cell Markers CD133, CD44, CD24: Association with AKT Isoforms and Radiation Resistance in Colon Cancer Cells
- (2014) Sara Häggblad Sahlberg et al. PLoS One
- Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts
- (2014) Suling Liu et al. Stem Cell Reports
- Understanding and targeting cancer stem cells: therapeutic implications and challenges
- (2013) Ke Chen et al. ACTA PHARMACOLOGICA SINICA
- Disulfiram targets cancer stem-like cells and reverses resistance and cross-resistance in acquired paclitaxel-resistant triple-negative breast cancer cells
- (2013) P Liu et al. BRITISH JOURNAL OF CANCER
- Therapy-induced enrichment of putative lung cancer stem-like cells
- (2013) Daniela P. Freitas et al. INTERNATIONAL JOURNAL OF CANCER
- The AKT inhibitor AZD5363 is selectively active in PI3KCA mutant gastric cancer, and sensitizes a patient-derived gastric cancer xenograft model with PTEN loss to Taxotere
- (2013) Jing Li et al. Journal of Translational Medicine
- Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden
- (2013) Khalid Abubaker et al. Molecular Cancer
- Dual Inhibition of PI3K and mTOR Mitigates Compensatory AKT Activation and Improves Tamoxifen Response in Breast Cancer
- (2013) Xiaosong Chen et al. MOLECULAR CANCER RESEARCH
- Triple Negative Breast Tumors in African-American and Hispanic/Latina Women Are High in CD44+, Low in CD24+, and Have Loss of PTEN
- (2013) Yanyuan Wu et al. PLoS One
- Evaluation of STAT3 Signaling in ALDH+ and ALDH+/CD44+/CD24− Subpopulations of Breast Cancer Cells
- (2013) Li Lin et al. PLoS One
- Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells
- (2012) P Liu et al. BRITISH JOURNAL OF CANCER
- Highly sensitive profiling of CD44+/CD24− breast cancer stem cells by combining global mRNA amplification and next generation sequencing: Evidence for a hyperactive PI3K pathway
- (2012) Olaf Hardt et al. CANCER LETTERS
- Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity
- (2012) Appalaraju Jaggupilli et al. Clinical & Developmental Immunology
- Aldehyde dehydrogenase: Its role as a cancer stem cell marker comes down to the specific isoform
- (2011) Paola Marcato et al. CELL CYCLE
- Targeting the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Network in Cancer Stem Cells
- (2011) A. M. Martelli et al. CURRENT MEDICINAL CHEMISTRY
- Triple-Negative Breast Cancer: An Unmet Medical Need
- (2011) C. A. Hudis et al. ONCOLOGIST
- Disulfiram Treatment Facilitates Phosphoinositide 3-Kinase Inhibition in Human Breast Cancer Cells In vitro and In vivo
- (2010) H. Zhang et al. CANCER RESEARCH
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aldehyde Dehydrogenase Activity of Breast Cancer Stem Cells Is Primarily Due To Isoform ALDH1A3 and Its Expression Is Predictive of Metastasis
- (2010) Paola Marcato et al. STEM CELLS
- Patterns of recurrence in the basal and non-basal subtypes of triple-negative breast cancers
- (2009) Sharon Nofech-Mozes et al. BREAST CANCER RESEARCH AND TREATMENT
- Time to disease recurrence in basal-type breast cancers
- (2009) Rebecca Dent et al. CANCER
- Distinct roles for isoforms of the catalytic subunit of class-IA PI3K in the regulation of behaviour of murine embryonic stem cells
- (2009) E. Kingham et al. JOURNAL OF CELL SCIENCE
- Pattern of metastatic spread in triple-negative breast cancer
- (2008) Rebecca Dent et al. BREAST CANCER RESEARCH AND TREATMENT
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
- (2008) Cornelia Liedtke et al. JOURNAL OF CLINICAL ONCOLOGY
- Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy
- (2008) Scott J. Dylla et al. PLoS One
- The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations
- (2008) A. Dubrovska et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started